InhyeAhnMD

PubMed

• 247 citations
  Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.
  Inhye E. Ahn, Chingiz Underbayev, Adam Albitar, Sarah E. M. Herman, Xin Tian
  Blood. 2017-03-16
• 34 citations
  Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials.
  John N Allan, Tait Shanafelt, Adrian Wiestner, Carol Moreno, Susan M O'Brien
  British Journal of Haematology. 2022-02-01
• 47 citations
  COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
  Lindsey E. Roeker, Toby A. Eyre, Meghan C. Thompson, Nicole Lamanna, Alexander Coltoff
  Blood. 2021-07-23

Abstracts/Posters

• A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib
  Inhye E Ahn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib Show Expansion of T-Cell Clonotypes Composed of Antitumor Cytotoxic CD8+ T-Cells
  Inhye E Ahn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Whole Exome Sequencing Reveals Multiple Driver Events in Chronic Lymphocytic Leukemia Patients with Acquired Ibrutinib Resistance
  Inhye E Ahn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's T...
  Inhye E Ahn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all